Senior insider sale
Chief Medical Officer at AKTIS ONCOLOGY, INC. — senior position signals high conviction
$1.39M
50K shares
What this filing means
CZIBERE AKOS plans to sell 50K shares of AKTIS ONCOLOGY, INC. valued at approximately $1.39M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/8/2026ACC: 0001950047-26-006961
Officer· Chief Medical Officer
Since Jan 2026
50K
Shares to sell
$1.39M
Approx. market value
50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Options Under a Registered Plan
Cash
7/8/2026
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2026 | Exercise of Options Under a Registered Plan Cash | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
50K
Market value
$1.39M
7/8/2026
Total
Units
50K
Value
$1.39M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/8/2026 | 50K | $1.39M | NASDAQ | Planned |
| Total | 50K | $1.39M | ||